Effect of PCSK9 Inhibitor on Contrast-Induced Acute Kidney Injury in Patients with Acute Myocardial Infarction Undergoing Intervention Therapy

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have been shown to inhibit pyroptosis and apoptosis, which play important roles in the development and progression of contrast-induced acute kidney injury (CI-AKI). However, to the best of our knowledge, no studies have investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yu, Zha, Lei, Zhang, Qi, Cao, Lu, Zhao, Ru, Ma, Jing, Hou, Kai, Pan, Yue, Cong, Hongliang, Li, Ximing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427281/
https://www.ncbi.nlm.nih.gov/pubmed/36051574
http://dx.doi.org/10.1155/2022/1638209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427281/
https://www.ncbi.nlm.nih.gov/pubmed/36051574
http://dx.doi.org/10.1155/2022/1638209

Ejemplares similares